MedTrace Logo

PARADISE: Predicting AF After Cardiac Surgery

NCT05255224 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 13684

Last updated 2025-01-23

No results posted yet for this study

Summary

The PARADISE study aims to develop and validate prediction tools to identify patients at risk of Atrial Fibrillation (AF) after cardiac surgery.

Conditions

  • Atrial Fibrillation New Onset

Interventions

OTHER

Not applicable as observational study

Not applicable as observational study

Sponsors & Collaborators

  • St. Bartholomew's Hospital

    collaborator OTHER

  • University College, London

    collaborator OTHER

  • Liverpool Heart and Chest Hospital NHS Foundation Trust

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • Peter Watkinson, MD · University of Oxford

  • Benjamin O'Brien, MD · Deutsches Herzzentrum der Charité

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05255224 on ClinicalTrials.gov